HO-1 nuclear accumulation and interaction with NPM1 protect against stress-induced endothelial senescence independent of its enzymatic activity.
HO-1 nuclear accumulation and interaction with NPM1 protect against stress-induced endothelial senescence independent of its enzymatic activity.
复制标题
HO-1 核积累以及与 NPM1 的相互作用可防止应激诱导的内皮衰老,与其酶活性无关
DOI:
10.1038/s41419-021-04035-6
复制
发表时间:
2021-07-26
影响因子:
9
通讯作者:
Li Z
中科院分区:
文献类型:
--
作者:
Luo W;Li J;Li Z;Lin T;Zhang L;Yang W;Mai Y;Liu R;Chen M;Dai C;Yang H;Lu J;Li H;Guan G;Huang M;Liu P;Li Z
Heme oxygenase-1 (HO-1) has attracted accumulating attention for its antioxidant enzymatic activity. However, the exact regulatory role of its non-enzymatic activity in the cardiovascular system remains unaddressed. Here, we show that HO-1 was accumulated in the nuclei of stress-induced senescent endothelial cells, and conferred protection against endothelial senescence independent of its enzymatic activity. Overexpression of ΔHO-1, a truncated HO-1 without transmembrane segment (TMS), inhibited H2O2-induced endothelial senescence. Overexpression of ΔHO-1H25A, the catalytically inactive form of ΔHO-1, also exhibited anti-senescent effect. In addition, infection of recombinant adenovirus encoding ΔHO-1 with three nuclear localization sequences (NLS), alleviated endothelial senescence induced by knockdown of endogenous HO-1 by CRISPR/Cas9. Moreover, repression of HO-1 nuclear translocation by silencing of signal peptide peptidase (SPP), which is responsible for enzymatic cleavage of the TMS of HO-1, exacerbated endothelial senescence. Mechanistically, nuclear HO-1 interacted with NPM1 N-terminal portion, prevented NPM1 translocation from nucleolus to nucleoplasm, thus disrupted NPM1/p53/MDM2 interactions and inhibited p53 activation by NPM1, finally resisted endothelial senescence. This study provides a novel understanding of HO-1 as a promising therapeutic strategy for vascular senescence-related cardiovascular diseases.
登录
查看更多内容
DOI:
10.1084/jem.20100977
发表时间:
2011-10-24
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Ghoreschi K;Brück J;Kellerer C;Deng C;Peng H;Rothfuss O;Hussain RZ;Gocke AR;Respa A;Glocova I;Valtcheva N;Alexander E;Feil S;Feil R;Schulze-Osthoff K;Rupec RA;Lovett-Racke AE;Dringen R;Racke MK;Röcken M
通讯作者:
Röcken M
影响因子:
21.3
作者:
Colombo, E;Marine, JC;Pelicci, PG
通讯作者:
Pelicci, PG
影响因子:
5
作者:
Donato AJ;Morgan RG;Walker AE;Lesniewski LA
通讯作者:
Lesniewski LA
影响因子:
9.7
作者:
Gevaert, Andreas B.;Shakeri, Hadis;Van Craenenbroeck, Emeline M.
通讯作者:
Van Craenenbroeck, Emeline M.
影响因子:
50.3
作者:
Kurki, S;Peltonen, K;Laiho, M
通讯作者:
Laiho, M